(Q33928085)

English

Where are We with current therapy?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

title

Where are We with current therapy? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

Sung JJ

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

publication date

1 January 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

volume

5 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

page(s)

S17-21; discussion S27-31

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

cites work

Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Effectiveness of Helicobacter pylori therapies in a clinical practice setting

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2000.0050S1017.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1523-5378.2000.0050S1017.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

PubMed publication ID

10828750

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10828750

retrieved

30 July 2017

(Q33928085)

Where are We with current therapy?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)